UK Workshops on Synthetic Biology Reveal Fascination, Worries | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The emerging field of synthetic biology offers "tremendous opportunity," such as the potential for treating diseases, improving crops, making new fuels, and cleaning up the environment, but the public also sees a variety of potential problems that could arise from the technology, according to a new public and stakeholder survey released today by a UK science funding group.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.